Please assess the completion status of the following clinical trial:

Trial Title: Advanced MRI in AAA

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult patients (≥ 18 years of age)~* Abdominal aortic aneurysm with a maximal aneurysm diameter of at least 30 mm~Exclusion Criteria:~* Contra-indications for MRI~* Severely reduced renal function (eGFR \< 30)~* Previous allergic reaction to intravenous contrast agents~* Suprarenal AAA~* Pararenal AAA~* Previous aneurysm repair~* Inflammatory aneurysm~* Mycotic or other infectious aneurysm~* Vasculitis~* Connective tissue disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Optimization phase (Type: None): The first five patients will be included for the optimization of the MRI sequences. This is to ensure that a standard protocol will work for different sizes of AAA. These patients will only be scanned once.
- Study phase (Type: None): This phase will commence after the optimization phase. This phase is where we want to assess the feasibility, reproducibility and association with disease severity between MRI parameters and AAA.~These twenty patients will be scanned twice, with an interval of 1 week ± 5 days.~The study will be completed when we have 20 patients with 2 scans for each sequence, or when a maximum number of 30 patients in the study phase have been scanned.

Based on this trial design, predict the completion outcome and termination type (if applicable).